Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review
Macrophages are involved in the whole process of atherosclerosis, which is characterized by accumulation of lipid and inflammation. Presently, clinically used lipid-lowering drugs cannot completely retard the progress of atherosclerosis. Liver X receptor (LXR) plays a key role in regulation of lipid...
Main Authors: | Tong-Mei Yang, Miao Miao, Wen-Qian Yu, Xue Wang, Fang-Jie Xia, Yan-Jie Li, Shou-Dong Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1147699/full |
Similar Items
-
The Role of Macrophage Iron Overload and Ferroptosis in Atherosclerosis
by: Jiedong Ma, et al.
Published: (2022-11-01) -
Ironing out macrophages in atherosclerosis
by: Wang Lei, et al.
Published: (2023-01-01) -
Sulforaphane Inhibits Foam Cell Formation and Atherosclerosis via Mechanisms Involving the Modulation of Macrophage Cholesterol Transport and the Related Phenotype
by: Shiyan Liu, et al.
Published: (2023-04-01) -
The Role of Macrophages in the Pathogenesis of Atherosclerosis
by: Alexander V. Blagov, et al.
Published: (2023-02-01) -
The role of macrophage in atherosclerosis: An overview
by: İbrahim Halil Damar, et al.
Published: (2020-12-01)